...
首页> 外文期刊>Journal of Pharmacopuncture >Influence of Prescribed Herbal and Western Medi-cine on Patients with Abnormal Liver Function Tests: A Retrospective Quasi-Experimental Study
【24h】

Influence of Prescribed Herbal and Western Medi-cine on Patients with Abnormal Liver Function Tests: A Retrospective Quasi-Experimental Study

机译:处方药和西药对肝功能检查异常患者的影响:一项回顾性的拟实验研究

获取原文
           

摘要

Objectives The aim of this study was to investigate the safety and the efficacy of Korean herbal, western and combination medicine use in patients with abnormal liver function tests. Methods We investigated nerve disease patients with abnor-mal liver function tests who were treated with Korean herbal, western and combination medicine at Dong-Eui University Oriental Hospital from January 2011 to August 2011. We co-mpared aspartic aminotransferase (AST), alanine aminotran-sferase (ALT), alkaline phosphatase (ALP) and total bilirubin (T-bil) levels before and after taking medicine and excluded patients who had liver-related disease when admitted. Results AST and ALT were decreased significantly in patients who had taken herbal, western medicine. AST, ALT and ALP were decreased significantly in patients who had taken comb-ination medicine. Compare to herbal medicine, AST, ALT and ALP were decreased significantly in patients who had taken western medicine, and ALT and ALP were decreased signifi-cantly in patients who had taken combination medicine. There were no significant differences between western and combin-ation medicine. Conclusions This study suggests that prescribed Korean herbal medicine, at least, does not injure liver function for patients’, moreover, it was shown to be effective in patients with abnormal liver function tests.
机译:目的本研究旨在探讨韩国草药,西药和联合药物在肝功能检查异常患者中的安全性和有效性。方法我们调查了2011年1月至2011年8月在东义大学东方医院接受韩国草药,西药和中西医结合治疗的肝功能异常的神经疾病患者。我们将天冬氨酸氨基转移酶(AST)和丙氨酸氨基-sferase(ALT),碱性磷酸酶(ALP)和总胆红素(T-bil)水平在服药前后,入院时排除了患有肝相关疾病的患者。结果服用草药,西药的患者AST和ALT均明显降低。服用联合用药的患者的AST,ALT和ALP明显降低。与草药相比,服用西药的患者AST,ALT和ALP显着降低,服用联合药物的患者ALT和ALP显着降低。西方医学和联合医学之间没有显着差异。结论:这项研究表明,至少韩国处方药不会损害患者的肝功能,而且被证明对肝功能检查异常的患者有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号